HPCSA. SAHPRA. POPIA. NHI Act. Aafiya is designed around South Africa's regulatory requirements — not bolted on after the fact. Compliance is architecture, not overhead.
South Africa's health regulatory landscape is complex but navigable. Aafiya's legal, clinical, and technical architecture addresses each regulator's requirements from the ground up.
Governing body for all health professionals in South Africa
Regulates medical devices, including AI/ML clinical decision support
SAHPRA Evidence File — auto-generated from day one: Aafiya's AI pre-consultation triage system stores every triage decision with model version, latency, triage category, and outcome. This produces the triage validation dataset, recall and precision metrics by category, and false-negative rate for EMERGENCY cases that SAHPRA requires for Class C/D AI device registration. Aafiya is building its regulatory dossier with every consultation — not as a post-hoc exercise after a pilot ends.
Prospective Pilot Quality Gates: Four measurable thresholds that Aafiya's pilot must pass before SAHPRA submission:
SA's primary data privacy legislation, fully operative since July 2021
DHA National Population Register (in development): SA ID verification against the Department of Home Affairs NPR at patient registration will confirm identity, eliminate fraudulent billing, and meet POPIA's data subject verification requirements. It also enables the SASSA grant verification pathway — ensuring patient identity matches benefit records for NHI capitation billing.
Establishes SA's single-purchaser universal healthcare system
Most healthtech startups build a product and then retrofit compliance. Aafiya does the opposite: each regulatory requirement is translated directly into an architectural or operational constraint before a line of code is written.
This approach is harder upfront but creates durable advantages: lower regulatory risk at launch, stronger investor confidence, and an NHI-ready platform that competitors cannot replicate without rebuilding from scratch.
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| SAHPRA classification delays market entry | Medium | High | Early engagement (Month 0), retrospective + prospective evidence, first-mover window exploited |
| NHI implementation delayed beyond 2032 | High | Medium | Dual revenue model — medical aid scheme billing is independently viable at full scale |
| HPCSA changes telemedicine rules | Low | High | Active HPCSA engagement; Booklet 10 (2021) explicitly enables the model; physician-in-the-loop satisfies all current guidance |
| POPIA enforcement action on health data | Low | High | SA-resident data, purpose-specific consent architecture, designated Information Officer, regular audits |
| AI clinical performance below SAHPRA quality gates | Medium | High | Conservative validation timeline (18 months), SA-specific training corpus, deterministic rules engine as safety net |
Request the full investor deck including the detailed regulatory strategy, clinical validation plan, and financial model.